Royalty Pharma plc Non Peo Neo Avg Comp Actually Paid Amt
Royalty Pharma plc (RPRX) reported Non Peo Neo Avg Comp Actually Paid Amt of $18.61 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-10.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-04-10
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2025-12-31 | $18.61M DEF 14A · filed 2026-04-10 |
| 2024-12-31 | $37.99M DEF 14A · filed 2026-04-10 |
| 2023-12-31 | $11.24M DEF 14A · filed 2026-04-10 |
| 2022-12-31 | $11.91M DEF 14A · filed 2026-04-10 |
| 2021-12-31 | $12.27M DEF 14A · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |